Cargando…

Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer

We previously reported MELK (maternal embryonic leucine zipper kinase) as a novel therapeutic target for breast cancer. MELK was also reported to be highly upregulated in multiple types of human cancer. It was implied to play indispensable roles in cancer cell survival and indicated its involvement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Suyoun, Suzuki, Hanae, Miyamoto, Takashi, Takamatsu, Naofumi, Tatsuguchi, Ayako, Ueda, Koji, Kijima, Kyoko, Nakamura, Yusuke, Matsuo, Yo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2012
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681500/ https://www.ncbi.nlm.nih.gov/pubmed/23283305

Ejemplares similares

Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2016)

Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2020)

Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer
por: Inoue, Hiroyuki, et al.
Publicado: (2016)

Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells
por: Kato, Taigo, et al.
Publicado: (2016)

p53-independent p21 induction by MELK inhibition
por: Matsuda, Tatsuo, et al.
Publicado: (2017)

Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX
por: Vougiouklakis, Theodore, et al.
Publicado: (2018)

Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia
por: Alachkar, Houda, et al.
Publicado: (2014)

GALNT6 Stabilizes GRP78 Protein by O-glycosylation and Enhances its Activity to Suppress Apoptosis Under Stress Condition
por: Lin, Jiaying, et al.
Publicado: (2017)

High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo
por: Ikeda, Yuji, et al.
Publicado: (2020)

2193: Targeting MELK in acute lymphoblastic leukemia, new therapeutic approach
por: Alachkar, Houda, et al.
Publicado: (2018)

Phosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors
por: Nakakido, Makoto, et al.
Publicado: (2016)

TOPK (T‐LAK cell‐originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer
por: Park, Jae‐Hyun, et al.
Publicado: (2017)

MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
por: Beke, Lijs, et al.
Publicado: (2015)

Correction: MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
por: Beke, Lijs, et al.
Publicado: (2018)

T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia
por: Alachkar, Houda, et al.
Publicado: (2015)

Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes
por: Ueda, Koji, et al.
Publicado: (2014)

Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma
por: Cigliano, Antonio, et al.
Publicado: (2019)

Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK
por: Gong, Xianling, et al.
Publicado: (2018)

Phosphorylation of the HIV-1 capsid by MELK triggers uncoating to promote viral cDNA synthesis
por: Takeuchi, Hiroaki, et al.
Publicado: (2017)

MELK—a conserved kinase: functions, signaling, cancer, and controversy
por: Ganguly, Ranjit, et al.
Publicado: (2015)

MELK is a novel therapeutic target in high-risk neuroblastoma
por: Guan, Shan, et al.
Publicado: (2017)

MELK is not necessary for the proliferation of basal-like breast cancer cells
por: Huang, Hai-Tsang, et al.
Publicado: (2017)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
por: Yang, Haiyan, et al.
Publicado: (2022)

Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells
por: Stefka, A T, et al.
Publicado: (2016)

Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1
por: Bollu, Lakshmi Reddy, et al.
Publicado: (2020)

MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
por: Zhang, Xu, et al.
Publicado: (2021)

Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer
por: Pickard, Mark R, et al.
Publicado: (2009)

MELK expression correlates with tumor mitotic activity but is not required for cancer growth
por: Giuliano, Christopher J, et al.
Publicado: (2018)

Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer
por: Laha, Dipranjan, et al.
Publicado: (2022)

Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family
por: Lin, Meng-Lay, et al.
Publicado: (2007)

Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
por: Zhang, Xu, et al.
Publicado: (2022)

MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
por: Joshi, Kaushal, et al.
Publicado: (2013)

A Conditional Dependency on MELK for the Proliferation of Triple-Negative Breast Cancer Cells
por: Wang, Yubao, et al.
Publicado: (2018)

Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation
por: Nakano, Ichiro, et al.
Publicado: (2005)

MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
por: Wang, Yubao, et al.
Publicado: (2014)

MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway
por: Xu, Qinyang, et al.
Publicado: (2020)

MEK/MELK inhibition and blood–brain barrier deficiencies in atypical teratoid/rhabdoid tumors
por: Meel, Michaël H, et al.
Publicado: (2020)

MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
por: Tang, Qin, et al.
Publicado: (2020)

Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer
por: Hardeman, Ashley A., et al.
Publicado: (2022)

Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK‑dependent manner
por: Lee, Da Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1jsndr94ncoa87ere5iuotkuq6